The CTP 2018 Programme is now posted!

Check back often for updates, or scroll below to join our mailing list and be notified as soon as updates are posted.

Conference Day 1

(click to expand)

May 15, 2018: Day 1

  • 7:30am-8:20am: Registration, Exhibits and Hot Breakfast Open
  • 8:30am – 8:45am: Chairman’s Address & Opening Remarks
  • 8:45am – 9:30am: KEYNOTE: Dr. Andrew Pelling | CSO, Spiderwort & TED Fellow >> Harnessing Curiosity & Serendipity to Drive Discovery and Translation
  • 9:30am – 10:15am: Plennary Session: Wout Brusselaers | CEO, Deep 6 AI >> How Artificial Intelligence is Transforming Clinical Trial Recruitment
  • 10:15am – 10:30am: Refreshment Break
  • 10:30am – 11:15am: Amanda Wright | Executive Director, Greater Gift >> Igniting Awareness in Clinical Research: the Power Behind the Patient
  • 11:15am – 12:00pm: Vatche Bartekian | President, Vantage BioTrials >> Getting Back on Track for Project Completion: Effective Strategies for Study Rescue
  • 12:00pm – 12:15pm: Special Award Presentation
  • 12:15pm – 1:30pm: Lunch
  • 1:30pm – 2:15pm: Concurrent Session: Filomena Servidio-Italiano | Director, Colorectal Cancer Canada >> Promoting Patient Group Integration in Canadian Cancer Clinical Trials
  • 1:30pm – 2:15pm: Concurrent Session: Sabrina Ramkellawan | VP, Clinical Affairs, TerrAscend >> Out with the Old, in with the E-Consent
  • 1:30pm – 2:15pm: Concurrent Session: Jamie Hutchison, MD | Staff Physician, Critical Care Medicine, Hospital for Sick Children >> Clearing the Hurdles for Drug Discovery and Clinical Trials in Concussion and Traumatic Brain Injury
  • 2:15pm – 3:00pm: Refreshment Break
  • 3:00pm – 3:45pm: Concurrent Session: Kim McDonald-Taylor | Clinical Research Consultant >> Navigating Health Canada’s Part C, Division 5 NEW Draft Guideline & How it Relates to ICH E6 (R2)
  • 3:00pm – 3:45pm: Concurrent Session: Susanne Picard | President, SPharm >> Overcoming Obstacles in the Drug Approval Process in Canada
  • 3:00pm – 3:45pm: Concurrent Session: Karri Venn | President, Research, LMC Manna Research >> Big Data, RWD & RWE: What’s the Difference and How is it Changing the Research Landscape?
  • 3:45pm – 4:15pm: Refreshment Break
  • 4:15pm – 5:00pm: Concurrent Session: John Amrhein | Vice-President, McDougall Scientific >> Your Stats and Study Design Questions Answered: an Interactive Q&A Session
  • 4:15pm – 5:00pm: Concurrent Session: Cheryl Petruk | Chair, Canadian MPN Research Foundation >> Breaking Down Barriers: a Patient’s Perspective on Improving Clinical Trial Opportunities
  • 4:15pm – 5:00pm: Concurrent Session: Dr. Neilank Jha, MD, FRCSC | Neurosurgeon & Spine Surgeon >> Integration of Medical Cannabis in Mainstream Pharmaceuticals
  • 5:30pm: Welcome Cocktail GALA (Hosted by the Clinical Research Association of Canada)

Conference Day 2

(click to expand)

May 16, 2018: Day 2

  • 7:15am-8:10am: Registration, Exhibits and Hot Breakfast Open
  • 8:10am – 8:40am: Special Guest Speaker
  • 8:45am – 9:30am: PATIENT KEYNOTE: T. J. Sharpe | Medical Hero >> The “Why” Behind Purposeful Patient Engagement
  • 9:30am – 11:00am: Workshop: Peggy Berry | President & CEO, Synergy Consulting >> Aligning Clinical Operations to the new ICH GCP E6 (R2)
  • 9:30am – 11:00am: Workshop: Janet McDougall| President, McDougall Scientific & Betsy Fallen | Principal, BAFallen Consulting >> Innovation Planning for Integrity and Success in Clinical Trials
  • 9:30am – 11:00am: Workshop: Sabrina Ramkellawan | VP, Clinical Affairs, TerrAscend & Kim McDonald-Taylor | Clinical Research Consultant >> Developing Full-Proof  Strategies for Patient Recruitment and Retention
  • 11:00am – 11:30am: Refreshment Break
  • 11:30am – 12:15pm: Plennary Session: Susan Marlin | President & CEO, Clinical Trials Ontario (CTO) and Linnea Aasen-Johnston | Industry Outreach Associate, CTO >> Opportunities for Streamlined Study Start-up: How Can We Get There?
  • 12:15pm – 1:30pm: Lunch
  • 1:30pm – 2:15pm: Concurrent Session: Nazneen Qureshi | Manager, LMC Manna Research >> How Investigative Sites Can Integrate Patients in the Clinical Development Process
  • 1:30pm – 2:15pm: Concurrent Session: Pierre Gervais | President, Q&T Research >> Are Clinical Trial Compensations a Taxable Benefit? Lessons Learned from a Canada Revenue Agency Audit
  • 1:30pm – 2:15pm: Concurrent Session: Andreas Orfanos | Director, MHICC >> Personalized Medicine: Challenges Leading to New Opportunities and Innovation in Clinical Trials
  • 2:15pm – 3:00pm: Plennary Session: Joseph Geraci | President & Founder, NetraMark >> Using Machine Learning & Augmented Intelligence to Overcome Difficulties in Phase III Clinical Trials
  • 3:00pm – 3:30pm: Refreshment Break
  • 3:30pm – 4:15pm: Plennary Session: Flora Noitsis | Specialist, GCPs, Health Canada >> Health Canada’s GCP Inspection Program: Ongoing Initiatives and Strategic Changes
  • 4:15pm – 4:30pm: Closing Remarks & End of Conference

Click here to download the latest PDF version of the Agenda.

Check back often for more updates!

Subscribe to our Newsletter to be notified when updates are made.